Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emma Rigg"'
Autor:
Emma Rigg, Jiwei Wang, Zhiwei Xue, Taral R. Lunavat, Guowei Liu, Tuyen Hoang, Himalaya Parajuli, Mingzhi Han, Rolf Bjerkvig, Petr V. Nazarov, Nathalie Nicot, Stephanie Kreis, Christiane Margue, Miléne Tetsi Nomigni, Jochen Utikal, Hrvoje Miletic, Terje Sundstrøm, Lars A. R. Ystaas, Xingang Li, Frits Thorsen
Publikováno v:
Journal of Extracellular Vesicles, Vol 12, Iss 10, Pp n/a-n/a (2023)
Abstract Melanoma has the highest propensity of all cancers to metastasize to the brain with a large percentage of late‐stage patients developing metastases in the central nervous system (CNS). It is well known that metastasis establishment, cell s
Externí odkaz:
https://doaj.org/article/13e6842bb53b4e6eb0815742a3304ee4
Autor:
Agathe Reigstad, Christina Frantzen Herdlevær, Emma Rigg, Tuyen Hoang, Ole Vidhammer Bjørnstad, Synnøve Nymark Aasen, Jasmin Preis, Claude Haan, Terje Sundstrøm, Frits Thorsen
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Melanomas frequently metastasize to the brain. Despite recent progress in the treatment of melanoma brain metastasis, therapy resistance and relapse of disease remain unsolved challenges. CCT196969 is a SRC family kinase (SFK) and Raf proto-oncogene,
Externí odkaz:
https://doaj.org/article/d9c9452bb87a44fba8f5993484f1886f
Autor:
Afnan Munshi, Jelica Mehic, Marybeth Creskey, Jonathan Gobin, Jun Gao, Emma Rigg, Gauri Muradia, Christian C. Luebbert, Carole Westwood, Andrew Stalker, David S. Allan, Michael J. W. Johnston, Terry Cyr, Michael Rosu-Myles, Jessie R. Lavoie
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-18 (2019)
Abstract Background Clinical applications have shown extracellular vesicles (EVs) to be a major paracrine effector in therapeutic responses produced by human mesenchymal stromal/stem cells (hMSCs). As the regenerative capacity of EVs is mainly ascrib
Externí odkaz:
https://doaj.org/article/699ae8e7d7ea4864b8c63797fe386e89
Autor:
Frits Thorsen, Rolf Bjerkvig, Emma Rigg, Tuyen Hoang, Taral R. Lunavat, Zichao Feng, Wenjing Zhou, Jiwei Wang
Publikováno v:
Neuro-oncology Advances
Background Melanoma has the highest propensity of any cancer to metastasize to the brain, with late-stage patients developing brain metastasis (MBM) in 40% of cases. Survival of patients with MBM is around 8 months with current therapies, illustratin